Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis
Trial details
- Registry ID
- NCT05671835
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of TTI-101 in Participants With Idiopathic Pulmonary FibrosisNCT05671835 | Tvardi Therapeutics, Incorporated | Phase 2 | Completed | 2025-08-14Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |